Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Arch Endocrinol Metab
2021 Nov 01;646:654-663. doi: 10.20945/2359-3997000000300.
Show Gene links
Show Anatomy links
Metabolomics as a potential tool for the diagnosis of growth hormone deficiency (GHD): a review.
De San-Martin BS
,
Ferreira VG
,
Bitencourt MR
,
Pereira PCG
,
Carrilho E
,
de Assunção NA
,
de Carvalho LRS
.
???displayArticle.abstract???
Metabolomics uses several analytical tools to identify the chemical diversity of metabolites present in organisms. These metabolites are low molecular weight molecules (<1500 Da) classified as a final or intermediary product of metabolic processes. The application of this omics technology has become prominent in inferring physiological conditions through reporting on the phenotypic state; therefore, the introduction of metabolomics into clinical studies has been growing in recent years due to its efficiency in discriminating pathophysiological states. Regarding endocrine diseases, there is a great interest in verifying comprehensive and individualized physiological scenarios, in particular for growth hormone deficiency (GHD). The current GHD diagnostic tests are laborious and invasive and there is no exam with ideal reproducibility and sensitivity for diagnosis neither standard GH cut-off point. Therefore, this review was focussed on articles that applied metabolomics in the search for new biomarkers for GHD. The present work shows that the applications of metabolomics in GHD are still limited, since the little complementarily of analytical techniques, a low number of samples, GHD combined to other deficiencies, and idiopathic diagnosis shows a lack of progress. The results of the research are relevant and similar; however, their results do not provide an application for clinical practice due to the lack of multidisciplinary actions that would be needed to mediate the translation of the knowledge produced in the laboratory, if transferred to the medical setting.
Abd Rahman,
Urine metabonomic profiling of a female adolescent with PIT-1 mutation before and during growth hormone therapy: insights into the metabolic effects of growth hormone.
2013, Pubmed
Abd Rahman,
Urine metabonomic profiling of a female adolescent with PIT-1 mutation before and during growth hormone therapy: insights into the metabolic effects of growth hormone.
2013,
Pubmed
Acharjee,
Integration of multi-omics data for prediction of phenotypic traits using random forest.
2016,
Pubmed
Barderas,
Metabolomic profiling for identification of novel potential biomarkers in cardiovascular diseases.
2011,
Pubmed
Biagetti,
Metabolic Fingerprint of Acromegaly and its Potential Usefulness in Clinical Practice.
2019,
Pubmed
Biller,
Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency.
2002,
Pubmed
Blum,
The growth hormone-insulin-like growth factor-I axis in the diagnosis and treatment of growth disorders.
2018,
Pubmed
Bravo-Merodio,
-Omics biomarker identification pipeline for translational medicine.
2019,
Pubmed
Cajka,
Toward Merging Untargeted and Targeted Methods in Mass Spectrometry-Based Metabolomics and Lipidomics.
2016,
Pubmed
Chong,
MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis.
2018,
Pubmed
Ciocan-Cartita,
The Relevance of Mass Spectrometry Analysis for Personalized Medicine through Its Successful Application in Cancer "Omics".
2019,
Pubmed
Collett-Solberg,
Diagnosis, Genetics, and Therapy of Short Stature in Children: A Growth Hormone Research Society International Perspective.
2019,
Pubmed
Crick,
Central dogma of molecular biology.
1970,
Pubmed
Deidda,
Metabolomic approach to profile functional and metabolic changes in heart failure.
2015,
Pubmed
Delgado-Rodríguez,
Systematic review and meta-analysis.
2018,
Pubmed
Djoumbou-Feunang,
BioTransformer: a comprehensive computational tool for small molecule metabolism prediction and metabolite identification.
2019,
Pubmed
Domingo-Almenara,
XCMS-MRM and METLIN-MRM: a cloud library and public resource for targeted analysis of small molecules.
2018,
Pubmed
Dona,
Translational and emerging clinical applications of metabolomics in cardiovascular disease diagnosis and treatment.
2016,
Pubmed
Elbornsson,
Seven years of growth hormone (GH) replacement improves quality of life in hypopituitary patients with adult-onset GH deficiency.
2017,
Pubmed
Emwas,
The strengths and weaknesses of NMR spectroscopy and mass spectrometry with particular focus on metabolomics research.
2015,
Pubmed
Fiehn,
Metabolomics--the link between genotypes and phenotypes.
2002,
Pubmed
Fleseriu,
Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline.
2016,
Pubmed
González-Domínguez,
Direct infusion mass spectrometry for metabolomic phenotyping of diseases.
2017,
Pubmed
Griffin,
Metabolomics as a tool for cardiac research.
2011,
Pubmed
Guijas,
Metabolomics activity screening for identifying metabolites that modulate phenotype.
2018,
Pubmed
Guijas,
METLIN: A Technology Platform for Identifying Knowns and Unknowns.
2018,
Pubmed
Haijes,
Direct Infusion Based Metabolomics Identifies Metabolic Disease in Patients' Dried Blood Spots and Plasma.
2019,
Pubmed
Höybye,
Metabolomics: a tool for the diagnosis of GH deficiency and for monitoring GH replacement?
2014,
Pubmed
Kamphorst,
Liquid chromatography-high resolution mass spectrometry analysis of fatty acid metabolism.
2011,
Pubmed
Khamis,
Mass spectrometric based approaches in urine metabolomics and biomarker discovery.
2017,
Pubmed
Kim,
Effects of growth hormone on glucose metabolism and insulin resistance in human.
2017,
Pubmed
Kosmides,
Metabolomic fingerprinting: challenges and opportunities.
2013,
Pubmed
Lai,
Identifying metabolites by integrating metabolome databases with mass spectrometry cheminformatics.
2018,
Pubmed
Lucas-Torres,
General Guidelines for Sample Preparation Strategies in HR-µMAS NMR-based Metabolomics of Microscopic Specimens.
2020,
Pubmed
Lynch,
Integrated Fluidic Circuits for Single-Cell Omics and Multi-omics Applications.
2019,
Pubmed
Malamud,
Saliva as a diagnostic fluid.
2011,
Pubmed
McBride,
Rapid liquid chromatography tandem mass spectrometry method for targeted quantitation of human performance metabolites in saliva.
2019,
Pubmed
Melmed,
Pathogenesis and Diagnosis of Growth Hormone Deficiency in Adults.
2019,
Pubmed
Mo,
Fracture risk in adult patients treated with growth hormone replacement therapy for growth hormone deficiency: a prospective observational cohort study.
2015,
Pubmed
Molitch,
Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline.
2011,
Pubmed
Moros,
Investigation of the derivatization conditions for GC-MS metabolomics of biological samples.
2017,
Pubmed
Narduzzi,
Applying metabolomics to detect growth hormone administration in athletes: Proof of concept.
2020,
Pubmed
Naz,
Analytical protocols based on LC-MS, GC-MS and CE-MS for nontargeted metabolomics of biological tissues.
2014,
Pubmed
Newgard,
Metabolomics and Metabolic Diseases: Where Do We Stand?
2017,
Pubmed
Ngamchuea,
Chemical analysis in saliva and the search for salivary biomarkers - a tutorial review.
2017,
Pubmed
Robinson,
Biomarkers to guide clinical therapeutics in rheumatology?
2016,
Pubmed
Romo-Hualde,
Untargeted metabolomic on urine samples after α-lipoic acid and/or eicosapentaenoic acid supplementation in healthy overweight/obese women.
2018,
Pubmed
Southam,
A complete workflow for high-resolution spectral-stitching nanoelectrospray direct-infusion mass-spectrometry-based metabolomics and lipidomics.
2016,
Pubmed
Tokarz,
Endocrinology Meets Metabolomics: Achievements, Pitfalls, and Challenges.
2017,
Pubmed
Wang,
High-Performance Liquid Chromatography-Mass Spectrometry-Based Lipid Metabolite Profiling of Acromegaly.
2020,
Pubmed
Willaschek,
Modified Clonidine Testing for Growth Hormone Stimulation Reveals α2-Adrenoreceptor Sub Sensitivity in Children with Idiopathic Growth Hormone Deficiency.
2015,
Pubmed
Wishart,
HMDB 4.0: the human metabolome database for 2018.
2018,
Pubmed
Worley,
PCA as a practical indicator of OPLS-DA model reliability.
2016,
Pubmed
Xia,
Translational biomarker discovery in clinical metabolomics: an introductory tutorial.
2013,
Pubmed
Xu,
Metabolomic analysis reveals metabolic characteristics of children with short stature caused by growth hormone deficiency.
2019,
Pubmed
Yu,
Metabolic profiling of acromegaly using a GC-MS-based nontargeted metabolomic approach.
2020,
Pubmed
Zhao,
Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis.
2012,
Pubmed